Thiazide
diuretics are effective antihypertensive medications shown to
reduce the risk of cardiovascular events and stroke. Despite being
the preferred choice for uncomplicated essential hypertension,
thiazide diuretics continue to be underutilized.
Methods: Uncomplicated essential hypertension patients taking
a single antihypertensive medication were evaluated upon enrollment,
diagnosis after enrollment or initiation of therapy in treatment
naïve patients. Clinician prescribing habits were determined
for both pre-existing and newly diagnosed hypertensive patients.
For the cost savings analysis, hydrochlorothiazide (HCTZ) 25mg
daily was selected as the preferred conversion medication.
Results: Four hundred seventy-eight patients were included. ACE
inhibitors were the most prescribed at 35.4% (n=169), followed
by dihydropyridine calcium channel blockers (DHP CCB) and thiazide
diuretics, both at 20.3% (n=97). Only 12.9% (n=33) of patients
with hypertension that were taking an antihypertensive medication
upon enrollment were either continued or started on thiazide diuretic
therapy. Newly diagnosed or treatment naïve patients were
prescribed a thiazide diuretic 28.8% (n=64) of the time. DHP CCB
accounted for 58.8% of the total medication cost per month with
thiazide diuretics responsible for 0.8% of the cost. If all patients
had been prescribed HCTZ 25mg daily, 95.8% of the total medication
cost per month could have been saved.
Conclusions: Thiazide diuretics were underutilized as preferred
therapy in patients with pre-existing or newly diagnosed uncomplicated
essential hypertension. While cost of therapy should not be the
sole reason for medication selection, thiazide diuretics are an
attractive option and should be considered as a preferred therapy
in this patient population.
Keywords:
Hypertension.
Economics, Pharmaceutical. Sodium Chloride Symporter Inhibitors.
United States.